A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation Research

• Publication date

  2012-07-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.112.267591PMID 22715469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-145 is differentially regulated by TGF-β1 and ischaemia and targets Disabled-2 expression and wnt/β-catenin activity

  2012cited by this paper
• MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling.

  2012cited by this paper
• Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs

  2012cited by this paper
• Role for miR-204 in human pulmonary arterial hypertension

  2011cited by this paper
• Transforming Growth Factor-β1 (TGF-β1) Utilizes Distinct Pathways for the Transcriptional Activation of MicroRNA 143/145 in Human Coronary Artery Smooth Muscle Cells*

  2011cited by this paper
• Down-regulation of Krüppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-β and Bone Morphogenetic Protein 4*

  2011cited by this paper
• Mammalian microRNAs predominantly act to decrease target mRNA levels

  2010cited by this paper
• Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline

  2010cited by this paper
• MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications

  2010cited by this paper
• miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

  2010cited by this paper
• MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro

  2010cited by this paper
• Identification of non-coding RNAs embracing microRNA-143/145 cluster

  2010cited by this paper
• MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.

  2009cited by this paper
• Faculty Opinions recommendation of miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.

  2009cited by this paper
• miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions

  2009cited by this paper
• Molecular mechanisms controlling E-cadherin expression in breast cancer.

  2009cited by this paper
• MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation

  2009cited by this paper
• MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.

  2009cited by this paper
• The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

  2009cited by this paper
• Dab2 stabilizes Axin and attenuates Wnt/β-catenin signaling by preventing protein phosphatase 1 (PP1)–Axin interactions

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster.

  2009cited by this paper
• Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway.

  2009cited by this paper
• Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

  2008cited by this paper
• SMAD proteins control DROSHA-mediated microRNA maturation

  2008cited by this paper
• Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions.

  2008cited by this paper
• In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

  2007cited by this paper
• Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis

  2007cited by this paper
• Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension

  2006cited by this paper
• Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension

  2005cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.

  2004cited by this paper
• Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.

  2002cited by this paper
• Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins

  2001cited by this paper
• Contribution of the 5-HT1B Receptor to Hypoxia-Induced Pulmonary Hypertension: Converging Evidence Using 5-HT1B-Receptor Knockout Mice and the 5-HT1B/1D-Receptor Antagonist GR127935

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• A new secreted protein that binds to Wnt proteins and inhibits their activites

  1999cited by this paper
• Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer.

  1997cited by this paper
• Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

  1993cited by this paper
• PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

  1987cited by this paper
• Transforming Growth Factor- (cid:1) 1 (TGF- (cid:1) 1) Utilizes Distinct Pathways for the Transcriptional Activation of MicroRNA 143/145 in Human Coronary Artery Smooth Muscle Cells

  year unknowncited by this paper

• Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment.

  2026cites this paper
• A Comprehensive Review of Epigenetic Regulation of Vascular Smooth Muscle Cells During Development and Disease

  2026cites this paper
• Advances in biomimetic nano delivery systems for pulmonary hypertension therapy.

  2025cites this paper
• Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease

  2025cites this paper
• Calcific aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk

  2025cites this paper
• Comorbidity of hypertension and lung cancer: interplay of genetics and environment

  2025cites this paper
• Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatment.

  2025cites this paper
• Targeting Soluble TGF-β Factors

  2024cites this paper
• N6-methyladenosine-driven miR-143/145-KLF4 circuit orchestrates the phenotypic switch of pulmonary artery smooth muscle cells

  2024cites this paper
• Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update

  2024cites this paper
• Epigenetic DNA Methylation and Protein Homocysteinylation: Key Players in Hypertensive Renovascular Damage

  2024cites this paper
• The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease

  2024cites this paper
• Non‐coding RNAs to treat vascular smooth muscle cell dysfunction

  2024influential citation
• CircPMS1 promotes proliferation of pulmonary artery smooth muscle cells, pulmonary microvascular endothelial cells, and pericytes under hypoxia

  2023cites this paper
• Noncoding RNAs in Pulmonary Arterial Hypertension: Current Knowledge and Translational Perspectives.

  2023cites this paper
• Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?

  2023cites this paper
• Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases

  2023cites this paper
• Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension

  2023cites this paper
• Vascular Mechanotransduction.

  2023cites this paper
• Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and delivery strategies.

  2023cites this paper
• Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.

  2023cites this paper
• MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment

  2022cites this paper
• Analysis of nocturnal, hypoxia-induced miRNAs in sleep apnea patients

  2022cites this paper
• Biomarkers in Pulmonary Arterial Hypertension

  2022cites this paper
• Aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk

  2022cites this paper
• Integrating Epigenetics and Metabolomics to Advance Treatments for Pulmonary Arterial Hypertension.

  2022cites this paper
• Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling

  2022cites this paper
• Stem cell‐derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy—In a model of human-induced pluripotent stem cell-derived cardiomyocytes

  2022cites this paper
• MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response

  2022cites this paper
• Recent advances on nanoparticle-based therapies for cardiovascular diseases.

  2022cites this paper
• Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension

  2022cites this paper
• Circulating microRNAs in the prediction of BAV aortopathy: do the expression patterns correlate between blood and aortic tissue?

  2022cites this paper
• MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents

  2022cites this paper
• Molecular Pathways in Pulmonary Arterial Hypertension

  2022cites this paper
• LncRNA PVT1 Promotes Hypoxia-Induced Cardiomyocyte Injury by Inhibiting miR-214-3p

  2021cites this paper
• Emerging role of exosomes in arterial and renal calcification

  2021cites this paper
• Novel Pharmacological Targets for Pulmonary Arterial Hypertension.

  2021cites this paper
• miR‐145 transgenic mice develop cardiopulmonary complications leading to postnatal death

  2021cites this paper
• Targeting Molecular and Cellular Mechanisms of Pulmonary Arterial Hypertension

  2021cites this paper
• Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger

  2021cites this paper
• Relationship between Functional miR-143/145 Cluster Variants and Susceptibility to Type 2 Diabetes Mellitus: A Preliminary Case-Control Study and Bioinformatics Analyses

  2021cites this paper
• MicroRNA-145-5p inhibits hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes by targeting ROCK1

  2021cites this paper
• The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

  2021cites this paper
• MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.

  2021cites this paper
• Extracellular matrix degradation pathways and fatty acid metabolism regulate distinct pulmonary vascular cell types in pulmonary arterial hypertension

  2021influential citation
• Bioinformatic analysis and validation of microRNA‐508‐3p as a protective predictor by targeting NR4A3/MEK axis in pulmonary arterial hypertension

  2021cites this paper
• Diverse roles of microRNA-145 in regulating smooth muscle (dys)function in health and disease.

  2021cites this paper
• CARMN Loss Regulates Smooth Muscle Cells and Accelerates Atherosclerosis in Mice

  2021cites this paper
• Intercellular Communication by Vascular Endothelial Cell-Derived Extracellular Vesicles and Their MicroRNAs in Respiratory Diseases

  2021cites this paper
• Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension

  2021cites this paper
• The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease

  2021cites this paper
• Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives

  2021cites this paper
• Emerging roles of let-7d in attenuating pulmonary arterial hypertension via suppression of pulmonary artery endothelial cell autophagy and endothelin synthesis through ATG16L1 downregulation

  2020cites this paper
• MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway

  2020cites this paper
• MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension

  2020cites this paper
• Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat

  2020cites this paper
• Emerging role of long non-coding RNAs in pulmonary hypertension and their molecular mechanisms (Review)

  2020cites this paper
• Epigenetic targets for oligonucleotide therapies of pulmonary hypertension

  2020cites this paper
• Pulmonary arterial hypertension specific therapy: The old and the new.

  2020cites this paper
• Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?

  2020cites this paper
• Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension

  2020cites this paper
• Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk

  2020cites this paper
• Non-coding RNAs: The key detectors and regulators in cardiovascular disease.

  2020cites this paper
• MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction

  2020influential citation
• Regulation of IRS-1, insulin signaling and glucose uptake by miR-143/145 in vascular smooth muscle cells.

  2020cites this paper
• MicroRNA sequences modulating inflammation and lipid accumulation in macrophage “foam” cells: Implications for atherosclerosis

  2020cites this paper
• Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis

  2020cites this paper
• Identification of key microRNAs and genes associated with abdominal aortic aneurysm based on the gene expression profile

  2019cites this paper
• MiR-19a modulates hypoxia-mediated cell proliferation and migration via repressing PTEN in human pulmonary arterial smooth muscle.

  2019cites this paper
• miRNA-9 inhibits apoptosis and promotes proliferation in angiotensin II-induced human umbilical vein endothelial cells by targeting MDGA2.

  2019cites this paper
• Chapter 4 p 53 and Vascular Dysfunction : MicroRNA in Endothelial Cells

  2019cites this paper
• Hypoxia‐induced Pulmonary Hypertension in Different Mouse Strains: Relation to Transcriptome

  2019cites this paper
• Retracted: Baicalin relieves TNF‐α‐evoked injury in human aortic endothelial cells by up‐regulation of miR‐145

  2019cites this paper
• Downregulation of miR-98 contributes to hypoxic pulmonary hypertension by targeting ALK1

  2019cites this paper
• [Advances in molecular mechanism of vascular remodeling in pulmonary arterial hypertension].

  2019cites this paper
• miR-145 improves metabolic inflammatory disease through multiple pathways

  2019cites this paper
• Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.

  2019cites this paper
• Epigenetics and vascular diseases.

  2019cites this paper
• Evolutionary Patterns of Non-Coding RNA in Cardiovascular Biology

  2019cites this paper
• The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease

  2019cites this paper
• Can microsomal RNA be a biomarker in pulmonary hypertension secondary to bronchopulmonary dysplasia?

  2019cites this paper
• Elucidating the contributory role of microRNA to cardiovascular diseases (a review)

  2019cites this paper
• Noncoding RNAs in Cardiovascular Disease

  2019cites this paper
• Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.

  2019cites this paper
• Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension

  2018cites this paper
• Recent advances in pulmonary arterial hypertension

  2018cites this paper
• Relationship of cardiovascular disease risk factors and noncoding RNAs with hypertension: a case-control study

  2018cites this paper
• Biomarkers in Pulmonary Hypertension.

  2018cites this paper
• Plasma miR-451 with echocardiography serves as a diagnostic reference for pulmonary hypertension

  2018cites this paper
• Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension

  2018cites this paper
• Mechanism of Immune Response Through mRNA/miRNA Effect in Vascular Dysfunctions

  2018cites this paper
• Pulmonary arterial hypertension: pathogenesis and clinical management

  2018cites this paper
• Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease

  2018cites this paper
• Loss of Vascular Myogenic Tone in miR-143/145 Knockout Mice Is Associated With Hypertension-Induced Vascular Lesions in Small Mesenteric Arteries

  2018cites this paper
• New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension.

  2018cites this paper
• Anti‐apoptosis endothelial cell‐secreted microRNA‐195‐5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension

  2018cites this paper
• Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude.

  2018influential citation
• Identification of suitable reference genes for real-time qPCR in homocysteine-treated human umbilical vein endothelial cells

  2018cites this paper
• Targeting Non-coding RNA in Vascular Biology and Disease

  2018cites this paper
• miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.

  2018cites this paper